Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hialeah, FL
NPI
1548299498
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
315 W 49th St, Suite A
Hialeah, FL, 33012
Phone (305) 820-4426
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
111 services
Medicare patients, 2024
60
Average age 74
Drug cost, 2024
$2.1M
6,611 prescriptions
Company payments, 2025
$2,202
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sonia M Jimenez-Victores was code 99214 (office e&m - established), 100 times for 55 patients. In total Sonia M Jimenez-Victores billed 111 services in 2 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 100 | 55 | $100.38 | $10K |
| 99204 Office E&M - New | Office | 11 | 11 | $141.52 | $1,557 |
By year: 2022 $20K for 178 services; 2023 $20K for 179 services; 2024 $12K for 111 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sonia M Jimenez-Victores prescribed most often to Medicare patients was Levothyroxine Sodium, with 815 prescriptions and refills. In total Sonia M Jimenez-Victores wrote 6,611 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 815 | 1,284 | 210 | $5,153 |
| Ozempic Semaglutide | 498 | 541 | 85 | $505K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 459 | 753 | 122 | $48K |
| Metformin Hcl Generic | 369 | 675 | 120 | $1,229 |
| Mounjaro Tirzepatide | 299 | 309 | 47 | $322K |
| Trulicity Dulaglutide | 244 | 246 | 47 | $232K |
| Tradjenta Linagliptin | 241 | 299 | 46 | $151K |
| Synthroid Levothyroxine Sodium | 226 | 387 | 52 | $18K |
| Jardiance Empagliflozin | 190 | 217 | 44 | $128K |
| Novolog Flexpen Insulin Aspart | 187 | 300 | 64 | $28K |
| Novolog Insulin Aspart | 183 | 196 | 31 | $39K |
| Januvia Sitagliptin Phosphate | 178 | 229 | 41 | $126K |
| Insulin Aspart Flexpen Insulin Aspart | 160 | 265 | 52 | $21K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 158 | 254 | 57 | $11K |
| Tresiba Flextouch U-100 Insulin Degludec | 123 | 196 | 23 | $63K |
Brand drugs: 4,020 claims; generic drugs: 2,144 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sonia M Jimenez-Victores $2,202 ($2,202 in general payments such as food, travel and fees) from 13 companies. The largest payer was Insulet Corporation with $1,394.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 11 | $1,394 |
| Medtronic, Inc. MDT | 23 | $433 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $122 |
| Mannkind Corporation MNKD | 1 | $42.5 |
| Novo Nordisk Inc NVO | 2 | $41.85 |
| Sequel Med Tech, LLC | 1 | $31.01 |
| Lilly USA, LLC LLY | 1 | $29.56 |
| Madrigal Pharmaceuticals MDGL | 1 | $26.88 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $26.51 |
| Dexcom, Inc. DXCM | 1 | $19.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.